In its earnings report, to be released Aug. 4, analysts estimate the pharmacy benefits manager will post earnings of $2.07 per share, a 21.59 percent year-over-year decrease.
However, the Zacks Consensus Estimate projects revenue of $70.08 billion, a 7.25 percent increase year over year, the article said.
